Updated September 2026Starter and full dose, pricedMANÜ Telehealth review
Two plans per molecule, split by dose rather than by term, with both figures published.
The verdict
MANÜ Telehealth publishes a Semaglutide Starter Plan from $199 and a Full Dose Plan at $299, read August 2026, with tirzepatide at $297 and $397. The split is by dose rather than by commitment length.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- $199/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
MANÜ Telehealth sells both molecules by injection across two plans each. The Starter Plan is described as entry pricing for patients starting or staying on lower doses.
Who writes the prescription, and what do they see?
A prescription precedes shipping and the clinician is not described. The plan names do the work instead, and they describe a clinical position rather than a billing term, which is unusual.
Almost every seller that varies price by term publishes the ladder; almost none that varies by dose does. MANÜ publishes the dose split directly, so a reader can see what escalating costs before they escalate. The distinction between starting and staying on lower doses is also stated, which acknowledges that some people do not move up.
What happens when the dose goes up?
This is the field MANÜ answers. Moving from the Starter Plan to the Full Dose Plan costs $100 a month on semaglutide and $100 on tirzepatide. A reader who expects to reach a full dose should price the second figure, not the first.
What the price includes
Six months on the Starter Plan is $1,194 for semaglutide and $1,782 for tirzepatide. On the Full Dose Plan the same spans are $1,794 and $2,382. The word starting attaches to both entry figures, so the Starter Plan has a floor of its own.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Both dose plans priced, not just the entry one
- Strength: The split is by dose, stated plainly
- Strength: Staying on a low dose is acknowledged
- Limitation: Full dose costs $100 more a month
- Limitation: Both entry figures say starting at
- Limitation: No milligram thresholds published
- Limitation: No state coverage list is recorded
What the evidence says about this kind of treatment
The assessment above is about MANÜ Telehealth. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants the cost of a full dose stated before starting a low one.
- Wrong for
- A reader budgeting a year from the Starter Plan figure.
How MANÜ Telehealth compares
| Seller | Who it suits | Go |
|---|---|---|
| MaxLife | Readers who want the figure pinned across a titration and read what a fee means here | See MaxLife → |
| LeanDose | Readers who will get the month-two rate in writing before the first charge | See LeanDose → |
 LevelUp Rx | Readers who want the billed total before committing to a term | See LevelUp Rx → |
More GLP-1 telehealth sellers reviews: EdgeRxEffectyElevated HealthEmbodyEnhance MDEverSlim
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- What does a full dose cost?
- $299 a month for semaglutide and $397 for tirzepatide, against Starter Plan figures of $199 and $297.
- Where is the line between the two plans?
- MANÜ describes the Starter Plan as entry pricing for patients starting or staying on lower doses, without publishing a milligram threshold.
- Is $199 a fixed rate?
- It is a starting figure for the Starter Plan, so it is a floor within the lower tier rather than a settled rate.
- Is MANÜ Telehealth expensive compared with other GLP-1 telehealth sellers?
- MANÜ Telehealth publishes a starting figure of $199/mo. Across the 149 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts MANÜ Telehealth above the median. The other 11 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.